3.55
price down icon3.27%   -0.12
after-market アフターアワーズ: 3.57 0.02 +0.56%
loading

Sellas Life Sciences Group Inc (SLS) 最新ニュース

pulisher
Feb 11, 2026

Sentiment Recap: Can SELLAS Life Sciences Group Inc beat the S P 500Dip Buying & Short-Term High Return Ideas - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 11, 2026

Surprises Report: Is Freeport McMoRan Incs growth already priced inQuarterly Performance Summary & AI Powered Market Entry Strategies - baoquankhu1.vn

Feb 11, 2026
pulisher
Feb 08, 2026

Market Review: How correlated is SPKLU to the S P5002025 Big Picture & Reliable Entry Point Trade Alerts - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 08, 2026

Forecast Cut: Does SELLAS Life Sciences Group Inc align with a passive investing strategyMarket Activity Report & Growth Focused Stock Pick Reports - baoquankhu1.vn

Feb 08, 2026
pulisher
Feb 04, 2026

Pharma News: Can SELLAS Life Sciences Group Inc stock double in the next year2025 Key Highlights & Community Consensus Picks - baoquankhu1.vn

Feb 04, 2026
pulisher
Feb 03, 2026

Aug Ideas: Should I hold or sell SELLAS Life Sciences Group Inc nowBull Run & AI Optimized Trade Strategies - baoquankhu1.vn

Feb 03, 2026
pulisher
Jan 29, 2026

Can SELLAS Life Sciences Group Inc beat the S P 5002025 Technical Patterns & Low Risk High Reward Ideas - baoquankhu1.vn

Jan 29, 2026
pulisher
Jan 29, 2026

Can SELLAS Life Sciences Group Inc. stock double in the next yearRate Cut & Low Volatility Stock Recommendations - mfd.ru

Jan 29, 2026
pulisher
Jan 27, 2026

SLS Stock Nears 52-Week High Amid Market Turbulence: What It Means for Investors - StocksToTrade

Jan 27, 2026
pulisher
Jan 27, 2026

Sellas Life Sciences Rallies as REGAL Debate Drives Momentum Toward 52-Week High - timothysykes.com

Jan 27, 2026
pulisher
Jan 23, 2026

Heightened Volatility Marks Sellas Life Sciences as Key Clinical Milestones Approach - AD HOC NEWS

Jan 23, 2026
pulisher
Jan 22, 2026

SLS Stock Price, Forecast & Analysis | SELLAS LIFE SCIENCES GROUP I (NASDAQ:SLS) - Chartmill

Jan 22, 2026
pulisher
Jan 21, 2026

Promising Penny Stocks To Add to Your WatchlistJanuary 1st - MarketBeat

Jan 21, 2026
pulisher
Jan 20, 2026

Sellas Life Sciences Rises as Traders Weigh REGAL Debate and Microcap Volatility - StocksToTrade

Jan 20, 2026
pulisher
Jan 20, 2026

SELLAS Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN

Jan 20, 2026
pulisher
Jan 19, 2026

Why I’m Selling Sellas Life Sciences Ahead Of The REGAL Reveal (NASDAQ:SLS) - Seeking Alpha

Jan 19, 2026
pulisher
Jan 18, 2026

Will SELLAS Life Sciences Group Inc. stock see PE expansion2025 Pullback Review & Proven Capital Preservation Methods - bollywoodhelpline.com

Jan 18, 2026
pulisher
Jan 18, 2026

Sellas Life Sciences Shares Surge with Strategic Clinical Study Moves - StocksToTrade

Jan 18, 2026
pulisher
Jan 18, 2026

SELLAS Life Sciences’ European Partnership Spurs Market Optimism - timothysykes.com

Jan 18, 2026
pulisher
Jan 17, 2026

Key Developments in SLS’s Market Strategy - StocksToTrade

Jan 17, 2026
pulisher
Jan 17, 2026

SELLAS Life Sciences Rallies After Major Trial Developments - timothysykes.com

Jan 17, 2026
pulisher
Jan 15, 2026

A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Collaboration - simplywall.st

Jan 15, 2026
pulisher
Jan 15, 2026

Sellas Life Sciences Stock Dips as Volatility Returns After Recent Headlines - StocksToTrade

Jan 15, 2026
pulisher
Jan 15, 2026

Sellas Life Sciences Expands SLS009 Program Into Europe With IMPACT-AML Agreement - StocksToTrade

Jan 15, 2026
pulisher
Jan 15, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Down 5.5%Should You Sell? - MarketBeat

Jan 15, 2026
pulisher
Jan 15, 2026

SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe - Sahm

Jan 15, 2026
pulisher
Jan 15, 2026

SELLAS partners with IMPACT-AML for European SLS009 trials By Investing.com - Investing.com Nigeria

Jan 15, 2026
pulisher
Jan 14, 2026

A Look At SELLAS Life Sciences Group (SLS) Valuation After New IMPACT AML Clinical Study Agreement - Yahoo Finance

Jan 14, 2026
pulisher
Jan 14, 2026

How SELLAS’s IMPACT-AML Trial Expansion At SELLAS Life Sciences Group (SLS) Has Changed Its Investment Story - simplywall.st

Jan 14, 2026
pulisher
Jan 14, 2026

SLS Stock In Spotlight On EU Expansion For Cancer Therapy – Retail Says Potential Catalyst For Buyout - Asianet Newsable

Jan 14, 2026
pulisher
Jan 14, 2026

SELLAS partners with IMPACT-AML for European SLS009 trials - Investing.com

Jan 14, 2026
pulisher
Jan 14, 2026

Sellas Life Sciences, Impact-AML Collaborate on EU Trial of SLS009 in Acute Myeloid Leukemia - marketscreener.com

Jan 14, 2026
pulisher
Jan 13, 2026

Aug Fed Impact: Is CACC trading at a discountVolume Spike & Fast Moving Stock Trade Plans - baoquankhu1.vn

Jan 13, 2026
pulisher
Jan 13, 2026

SELLAS Life Sciences Group Stock (SLS) Opinions on Phase 3 REGAL Trial Progress - Quiver Quantitative

Jan 13, 2026
pulisher
Jan 12, 2026

SELLAS Life Sciences Group (NASDAQ:SLS) Stock Price Up 10.3%Here's What Happened - MarketBeat

Jan 12, 2026
pulisher
Jan 12, 2026

Sellas Life Sciences Jumps in Volatile Session After Recent Selloff - StocksToTrade

Jan 12, 2026
pulisher
Jan 12, 2026

Best Penny Stocks To Follow TodayJanuary 4th - MarketBeat

Jan 12, 2026
pulisher
Jan 11, 2026

Sellas Life Sciences Rebounds After Volatile Selloff - timothysykes.com

Jan 11, 2026
pulisher
Jan 10, 2026

Sellas Life Sciences Stock Slides as Trading Dynamics Overshadow Trial Timeline Update - StocksToTrade

Jan 10, 2026
pulisher
Jan 10, 2026

Published on: 2026-01-10 22:25:31 - Улправда

Jan 10, 2026
pulisher
Jan 09, 2026

SELLAS Stock Dips Amid Volatility After Warrant Exercise Update - StocksToTrade

Jan 09, 2026
pulisher
Jan 09, 2026

Sellas Life Sciences falls for fourth straight session — what’s driving the sell-off? - MSN

Jan 09, 2026
pulisher
Jan 09, 2026

SELLAS Life Sciences Falls For Fourth Straight Session — What’s Driving The Sell Off? - Asianet Newsable

Jan 09, 2026
pulisher
Jan 09, 2026

SLS Stock Slides Amid Volatility as Traders Focus on Dilution Concerns - timothysykes.com

Jan 09, 2026
pulisher
Jan 09, 2026

SELLAS Life Sciences Falls For Fourth Straight SessionWhat's Driving The Sell Off? - Menafn

Jan 09, 2026
$44.80
price up icon 1.24%
$26.75
price down icon 0.19%
$100.75
price up icon 1.93%
$105.76
price down icon 3.31%
$146.17
price down icon 1.52%
biotechnology ONC
$346.42
price down icon 1.38%
大文字化:     |  ボリューム (24 時間):